AGMB — AgomAb Therapeutics NV

—
Nasdaq · Health Care · Biotechnology · CIK 2020932 · Belgium
Last close
$5.92
Market Cap
$291.55M
52W High
$17.82
52W Low
$5.50
ADV30
231,795
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — 290,923,000 221,588,000 25,547,000
Dec 2025 0 — -16,527,000 -17,401,000 153,706,000 86,418,000 22,804,000
Sep 2025 0 — -15,356,000 -18,278,000 165,631,000 129,585,000 18,700,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-26,809,000
Investing CF
$-30,004,000
Financing CF
$-190,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-212,617,000
Inventory
—
Receivables
$4,085,000
ST Investments
$30,389,000
EBIT TTM
$-35,694,000
Pretax Income TTM
$-35,679,000
Interest Exp TTM
$-15,000
Analysts
6

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -59,275,000 -62,547,000 153,706,000 22,804,000 130,902,000 -51,741,000
Dec 2024 0 -48,021,000 -46,267,000 206,358,000 18,277,000 188,081,000 -46,828,000
Dec 2023 0 -31,190,000 -11,390,000 171,259,000 19,824,000 151,435,000 -24,592,000
Dec 2022 0 -22,634,000 -8,142,000 100,995,000 34,747,000 66,248,000 -18,967,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.07

Peers — same industry

TickerNameMarket CapLastDaily %
AUTL Autolus Therapeutics plc $290.12M $1.09 —
KYTX Kyverna Therapeutics, Inc. $297.14M $4.70 —
SCTX Scribe Therapeutics, Inc. $298.64M $15.77 —
EDIT Editas Medicine, Inc. $281.67M $1.83 —
AGEN AGENUS INC $280.98M $6.21 —

News headlines (Yahoo Finance, 1h cache)

Agomab to Participate in Upcoming Investor Conferences
2026-11-04 21:05 · Yahoo
Agomab to Present STENOVA Open-Label Extension Data of Ontunisertib at UEG Week 2026 and Host Scientific Symposium on Fibro-Inflammation
2026-10-08 20:05 · Yahoo
Agomab stock jumps on positive trial data
2026-10-01 13:27 · Yahoo
Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study
2026-09-14 20:05 · Yahoo
Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
2026-09-11 20:05 · Yahoo
Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
2026-08-10 20:07 · Yahoo
Agomab Reports Half Year 2026 Financial Results and Confirms 2026 Outlook
2026-08-06 20:01 · Yahoo
Is AgomAB Therapeutics NV (AGMB) Stock a Biotech Opportunity With Targeted Tissue Therapy Potential?
2026-07-02 20:06 · Yahoo
Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease
2026-06-23 20:05 · Yahoo
Agomab to Participate in Upcoming Conferences
2026-05-14 11:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.